These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 10585756

  • 1. Suppression of systemic lupus erythematosus disease in mice by oral administration of kidney extract.
    Ofosu-Appiah W, Sfeir G, Viti D, Burashnikova E.
    J Autoimmun; 1999 Dec; 13(4):405-14. PubMed ID: 10585756
    [Abstract] [Full Text] [Related]

  • 2. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 3. B cell apoptosis accelerates the onset of murine lupus.
    Trébéden-Nègre H, Weill B, Fournier C, Batteux F.
    Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [Abstract] [Full Text] [Related]

  • 5. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis.
    Guo H, Leung JC, Chan LY, Chan TM, Lai KN.
    Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950
    [Abstract] [Full Text] [Related]

  • 6. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, Putterman C.
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [Abstract] [Full Text] [Related]

  • 7. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 8. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC, Martin D, Zhang K, Hudkins KL, Alpers CE, Clark EA, Elkon KB.
    Arthritis Rheum; 2009 Jun 15; 60(6):1775-84. PubMed ID: 19479860
    [Abstract] [Full Text] [Related]

  • 9. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY, Zhou WX, Zhang YX, Cheng JP, He JF, Yang RF, Yun LH.
    Life Sci; 2007 Oct 27; 81(19-20):1403-10. PubMed ID: 17950363
    [Abstract] [Full Text] [Related]

  • 10. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E, Lee Y, Park N, Cho C, Yim YN, Kim J, Kim YS, Kim D, Shin MK, Hong MC, Bae H.
    Lupus; 2007 Oct 27; 16(5):335-41. PubMed ID: 17576735
    [Abstract] [Full Text] [Related]

  • 11. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P, Langnickel D, Riemekasten G.
    Scand J Rheumatol; 2006 Oct 27; 35(3):209-16. PubMed ID: 16766368
    [Abstract] [Full Text] [Related]

  • 12. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
    Wen X, Zhang D, Kikuchi Y, Jiang Y, Nakamura K, Xiu Y, Tsurui H, Takahashi K, Abe M, Ohtsuji M, Nishimura H, Takatsu K, Shirai T, Hirose S.
    Eur J Immunol; 2004 Oct 27; 34(10):2740-9. PubMed ID: 15368290
    [Abstract] [Full Text] [Related]

  • 13. Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate.
    Ofosu-Appiah W, Sfeir G, Viti D, Burashnikova E.
    Cell Immunol; 1998 Jan 10; 183(1):22-31. PubMed ID: 9578716
    [Abstract] [Full Text] [Related]

  • 14. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin-binding peptide.
    Marino M, Ruvo M, De Falco S, Fassina G.
    Nat Biotechnol; 2000 Jul 10; 18(7):735-9. PubMed ID: 10888840
    [Abstract] [Full Text] [Related]

  • 15. Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.
    Ravirajan CT, Wang Y, Matis LA, Papadaki L, Griffiths MH, Latchman DS, Isenberg DA.
    Rheumatology (Oxford); 2004 Apr 10; 43(4):442-7. PubMed ID: 15024133
    [Abstract] [Full Text] [Related]

  • 16. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Hagiwara E, Okubo T, Aoki I, Ohno S, Tsuji T, Ihata A, Ueda A, Shirai A, Okuda K, Miyazaki J, Ishigatsubo Y.
    Cytokine; 2000 Jul 10; 12(7):1035-41. PubMed ID: 10880249
    [Abstract] [Full Text] [Related]

  • 17. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A.
    Int Immunol; 2004 Jul 10; 16(7):937-46. PubMed ID: 15148287
    [Abstract] [Full Text] [Related]

  • 18. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct 10; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 19. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
    Hayashi T, Hasegawa K, Sasaki Y, Mori T, Adachi C, Maeda K.
    Nephrol Dial Transplant; 2007 Nov 10; 22(11):3131-8. PubMed ID: 17670770
    [Abstract] [Full Text] [Related]

  • 20. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY, Hwang SY, Park KS, Lee JS, Lee KE, Kim KW, Jung YO, Koh HJ, Do JH, Kim H, Kim HY.
    Arthritis Res Ther; 2004 Nov 10; 6(3):R213-9. PubMed ID: 15142267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.